Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-008874
Filing Date
2023-02-13
Accepted
2023-02-13 18:40:57
Documents
2
Period of Report
2023-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1606
2 EX-24 DOCUMENT attachment1.htm EX-24 2309
  Complete submission text file 0001209191-23-008874.txt   5323
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE DUBLIN L2 D02 T390
Business Address
Williamson Douglas J (Reporting) CIK: 0001911501 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 23620823